12.75
A PLUS-quotedCompany
Open
Ivy Medical Chemicals plc is an innovative pharmaceutical company whose principal activity is in the development of a patented combination product called CV247. CV247 has been the subject of a series of studies in companion animals and human patients to assess its potential as a possible treatment for various cancers and its positive effect on quality of life.In animals, CV247 has been Studied in several trials in mice and two studies in dogs in the UK have been undertaken.